These testicular lymphomas, which mainly affected older men, primarily develop in the testis, an immune-privileged site, in other words a place that for physiological reasons is less subject to immune...
Read more
New next generation sequencing-based proteomics kits designed to integrate with multiple NGS platforms, eliminating the need for new instrumentation or specialized expertise
Read more
A multicenter collaboration leaded by the Bellvitge Biomedical Research Institute (IDIBELL), the Catalan Institute of Oncology (ICO) and the Germans Trias i Pujol Research Institute (IGTP) identified ...
Read more
An international scientific team, led by the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), has designed a chemical compound called MACTIDE-V, capable of reprogramming the activity of thes...
Read more
Un estudio del CBM y la UCM muestra que estos tumores reprograman a los monocitos, un tipo de glóbulo blanco protector, para transformarlos en macrófagos que no solo no atacan al cáncer sino que su...
Read more
IDIBELL’s spin-off Aptadel Therapeutics develops RNA-based molecules to find alternative treatments against cancer that are more effective and less toxic than current ones.
Read more
La URV lidera esta investigación que revela el papel de dos vías moleculares clave en la conexión entre nervios y músculos, un descubrimiento determinante para avanzar en el tratamiento de este ti...
Read more
Varios equipos del Centro de Investigación Biomédica en Red (CIBER) en el Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz y el Institut d'Investigacions Biomèdiques (IibB) San...
Read more
A team led by Dr. Malu Martínez-Chantar, from CIC bioGUNE, has identified a new therapeutic target to treat alcohol-associated liver disease (ALD), focusing on the modulation of the magnesium transpo...
Read more
Un análisis multi-ómico en fibroblastos de pacientes con la enfermedad de la orina de jarabe de arce (MSUD) descubrió una firma epigenética especifica que afecta la forma en que se regula el ADN. ...
Read more
El estudio servirá de base a dos ensayos internacionales para comprobar la eficacia del fármaco Azeliragon en estos tumores cerebrales agresivos
Read more
Now, a study led by the University of Barcelona confirms the therapeutic efficiency of a new compound against psoriasis, which could avoid the risks associated with previously known therapies. The stu...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
